(R)-N-(β-三氯锗丙酰基)四氢噻唑-2-硫酮-4-羧酸甲酯的合成及其晶体结构

三氯锗丙酰氯与(R)-四氢噻唑-2-硫酮-4-羧酸甲酯反应, 得到标题化合物1, [α]~D^2^0-89.40°。经水解得到取代丙酰四氢噻唑-2-硫酮-4-羧酸甲酯基锗倍半氧化物2, X射线衍射法测出标题化合物的晶体结构, 属于正交晶系, 晶胞参数: a=0.6192(1)nm,b=1.1147(4)nm,c=2.1796(8)nm, V=1.5045nm^3, Z=4, 空间群P2~12~12~1。分子中酰胺羰基C=O与C=S基团处于C(4)NC(3)键两侧呈反式。用MNDO分子轨道方法研究了该化合物的电子结构, 电荷和键序分布,前沿轨道性质,讨论了电子光谱性质。     

3-(9-芴甲氧羰基)四氢噻唑-2-硫酮的合成及其晶体结构

在吡啶存在下, 由9-芴甲氧羰酰氯与四氢噻唑-2-硫酮反应得到3-(9-芴甲氧羰基)四氢噻唑-2-硫酮, 产率为78.0%。用X射线衍射法测定晶体结构, 属正交晶系, Pca21空间群, 晶体学参数:a=0.9654(2), b=2.8032(1), c=0.6069(2)nm, Z=4。分子中的C=O与C=S基团处在C(3)-N-C(4)键的同侧, 为顺式结构。用PM3分子轨道方法研究该化合物的电子结构、电荷和键序分布、前线轨道性质。     

(R)-N-(β-三氯锗丙酰基)四氢噻唑-2-硫酮-4-羧酸甲酯的合成及其晶体结构

三氯锗丙酰氯与(R)-四氢噻唑-2-硫酮-4-羧酸甲酯反应, 得到标题化合物1, [α]~D^2^0-89.40°。经水解得到取代丙酰四氢噻唑-2-硫酮-4-羧酸甲酯基锗倍半氧化物2, X射线衍射法测出标题化合物的晶体结构, 属于正交晶系, 晶胞参数: a=0.6192(1)nm,b=1.1147(4)nm,c=2.1796(8)nm, V=1.5045nm^3, Z=4, 空间群P2~12~12~1。分子中酰胺羰基C=O与C=S基团处于C(4)NC(3)键两侧呈反式。用MNDO分子轨道方法研究了该化合物的电子结构, 电荷和键序分布,前沿轨道性质,讨论了电子光谱性质。     

3-苄氧羰基四氢噻唑-2-硫酮的晶体结构与量子化学研究

苄氧羰酰氯与四氢噻唑-2-硫酮在三乙胺存在下反应生成了3-苄氧羰基四氢噻唑-2-硫酮。在甲醇中培养了标题化合物单晶,用X射线衍射法进行了结构表征。晶体结构属三斜晶系,P1间群,晶体学参数:a=0.6274(2)nm,b=0.7340(3)nm,c=1.2976(4)nm;α=100.73(3)°,β=94.53(3)°,γ=103.28(3)°,Z=2,M_μ=4.30cm^-1.分子中的>C=O与>C=S基团处于C(4)-N-C(1)键的同侧,为顺式。用PM₃分子轨道方法研究了该化合物的电子结构,得到电荷和键序分布以及前线轨道等性质。     

四氢噻唑-2-硫酮的晶体结构及分子结构

四氢噻唑-2-硫酮晶体属单斜晶系,空间群P2_1/n;晶胞参数a=13.844(7)A,b=5.614(2)A,c=13.516(7)A,β=95.08(5)°;V=1046.3(9)A~3;Z=8。衍射强度数据系在Syntex R3四圆衍射仪上收集。结构的初始模型用直接法解得,经块矩阵最小二乘精修后,R值为0.082。结构分析表明分子结构介于1和2之间,分子中S(1)、S(2)、N、C(1)等原子共面,具有共轭效应。用自编CNDO/2程序计算了四氢噻唑硫酮及N-苯甲酰基四氢噻唑硫酮的原子荷电密度、偶极矩及总能量.解释了苯甲酰基四氢噻唑硫酮的生色效应及胺解性能。     

光学活性N-肉桂酰R(S)-4-异丙基四氢噻唑-2-硫酮的合成及其 量子化学的研究

用KBH~4,CaCl~2为还原使D及L缬氨酸甲酯还原得到光学活性产物R-3-甲基-2-氨基丁醇(2a)及S-3-甲基-2-氨基丁醇(2b)。2a,2b同CS~2在KOH存在下反应得到(R)-4-异丙基四氢噻唑-2-硫酮(3a)及(S)-4-异丙基四氢噻唑-2-硫酮(3b)。肉桂酰氯分别同3a及3b在Et~3N存在下反应得到N-肉桂酰(R)-4-异丙基四氢噻唑-2-硫酮(4a)及N-肉桂酰(S)-4-异丙基四氢噻唑-2-硫酮(4b)。用半经验的量子化学PM3方法研究了反应物和产物的电子结构,得到了产物的最优构型和电荷键序分布以及反应焓变。     

噻唑啉-2-硫酮衍生物的合成与生物活性

根据活性亚结构拼接原理,将3-芳基-4-氨基-5-乙氧羰基(氰基)-3H-噻唑啉-2-硫酮与酰氯反应得到目标化合物3-芳基-4-取代苯氧乙酰氨基-5-乙氧羰基(氰基)-3H-噻唑啉-2-硫酮.再以3-苯基-4-氨基-5-乙氧羰基-3H-噻唑啉-2-硫酮为合成原料,经过Aza-Wittig反应得到目标化合物5-芳氧基-3,6-二芳基-2-硫代噻唑并[4,5-d]嘧啶-7-酮.通过IR,1H NMR,EI-MS,元素分析等方法对所合成的化合物进行了结构表征.代表化合物5-对氯苯氧基-3,6-二苯基-2-硫代-2,3-二氢噻唑并[4,5-d]嘧啶-7(6H)-酮(C1)经单晶X衍射证实了结构.除草活性测试结果表明:部分噻唑啉-2-酮类衍生物对稗草和油菜都表现出了较好的抑制活性.     

光学活性N-肉桂酰R(S)-4-异丙基四氢噻唑-2-硫酮的合成及其量子化学的研究

用KBH_4,CaCl_2为还原剂使D及L缬氨酸甲酯还原得到光学活性产物R-3-甲基-2-氨基丁醇(2a)及S-3-甲基-2-氨基丁醇(2b)。2a,2b同CS_2在KOH存在下反应得到(R)-4-异丙基四氢噻唑-2-硫酮(3a)及(S)-4-异丙基四氢噻唑-2-硫酮(3b)。肉桂酰氯分别同3a及3b在Et_3N存在下反应得到N-肉桂酰(R)-4-异丙基四氢噻唑-2-硫酮(4a)及N-肉桂酰(S)-4-异丙基四氢噻唑-2-硫酮(4b)。用半经验的量子化学PM3方法研究了反应物和产物的电子结构,得到了产物的最优构型和电荷键序分布以及反应焓变。     

4-(2'-羟基苯甲酰肼)苯亚甲基／亚乙基－5－甲基－2－苯基－2，4－二氢－吡唑啉酮－3超分子化合物的合成与晶体结构

报道了4-(2'－羟基苯甲酰肼)苯亚甲基－5－甲基－2－苯基－2，4－二氢－吡 唑啉酮－3（B_1）和4-(2'－羟基苯甲酰肼)亚乙基－5－甲基－2－苯基－2，4－二 氢－吡唑啉酮－3（B_2）的合成、表征及晶体结构分析，B_1晶体属单斜晶系， C2/c空间群，所得晶胞参数为：a = 1.4201(2) nm, b = 1.65542(2) nm, c = 1. 8455(3) nm, β = 101.32(1)°，V = 4.2541(10) nm~3, Z = 8, D_c = 1.344 g/cm~3, μ = 0.094 mm~(-1), F(000) = 1808, R = 0.0442, wR = 0.1037。该 化合物由水分子通过氢键连接成沿ac面无限延伸的二维网络结构的超分子。B_2晶 体属三斜晶系，P1空间群，a = 1.2120(2) nm, b = 1.2223 (2) nm, c = 1.4159 (3) nm, α = 70.38 (1)°, β = 74.91 (1)°, γ = 63.64(1)°, V = 1.7549 (5)° nm~3, Z = 4, D_c = 1.326 g/cm~3, μ = 0.092 mm~(-1), F(000) = 736, R = 0.0436, wR = 0.1076。此化合物通过分子间氢键形成沿α轴无限延伸的一维 链状结构的超分子，由于分子间的作用力使其分子又沿b轴呈层状堆积。     

4-(2'-羟基苯甲酰肼)苯亚甲基／亚乙基－5－甲基－2－苯基－2，4－二氢－吡唑啉酮－3超分子化合物的合成与晶体结构

报道了4-(2'－羟基苯甲酰肼)苯亚甲基－5－甲基－2－苯基－2，4－二氢－吡 唑啉酮－3（B_1）和4-(2'－羟基苯甲酰肼)亚乙基－5－甲基－2－苯基－2，4－二 氢－吡唑啉酮－3（B_2）的合成、表征及晶体结构分析，B_1晶体属单斜晶系， C2/c空间群，所得晶胞参数为：a = 1.4201(2) nm, b = 1.65542(2) nm, c = 1. 8455(3) nm, β = 101.32(1)°，V = 4.2541(10) nm~3, Z = 8, D_c = 1.344 g/cm~3, μ = 0.094 mm~(-1), F(000) = 1808, R = 0.0442, wR = 0.1037。该 化合物由水分子通过氢键连接成沿ac面无限延伸的二维网络结构的超分子。B_2晶 体属三斜晶系，P1空间群，a = 1.2120(2) nm, b = 1.2223 (2) nm, c = 1.4159 (3) nm, α = 70.38 (1)°, β = 74.91 (1)°, γ = 63.64(1)°, V = 1.7549 (5)° nm~3, Z = 4, D_c = 1.326 g/cm~3, μ = 0.092 mm~(-1), F(000) = 736, R = 0.0436, wR = 0.1076。此化合物通过分子间氢键形成沿α轴无限延伸的一维 链状结构的超分子，由于分子间的作用力使其分子又沿b轴呈层状堆积。     

Synthesis and Crystal Structure of （R）-4-Hydroxymethyl-2-thioxo Thiazolidine and Its Asymmetric Catalysis

(R)-4-Hydroxymethyl-2-thioxo thiazolidine as a new chiral catalyst in the asymmetric addition of diethyl-zinc to benzaldehyde was synthesized from (R)-4-hydroxymethyl-2-thioxo thiazolidine carboxylic acid and its crystal structure was determined by X-ray diffraction method. The compound was crystallized in the orthorhombic system, space group P212121 with unit cell dimensions a=0.67253(12) nm; b=0.89164(17) rim; c=1.06146(19) nm, volume 0.6365(2) nm3; Z=4, calculated denisity 1.557 Mg/m3; absorption coefficient 0.733 mm-1; F(000)=312. The X-ray crystal structure analysis reveals that the compound has a thione group.     

Synthesis and Crystal Structure of a New Quinazolinone Compound 2,3-Dihydro-2-（2-hydroxyphenyl）-3-phenyl-quinazolin-4（1H）-one

A new quinazolinone compound 2,3-dihydro-2-(2-hydroxyphenyl)-3-phenylquinazolin-4(IH)-one 3 ([C2oH16O2N2]-C2H5OH, Mr = 362.42) and compound 2-(2-hydroxybenzylidene-amino)-N-phenyl-benzamide 2 (C2oH16O2N2, Mr = 316.34) were prepared from a precursor of 2-amino-N-phenyl-benzamide 1 (C13H12ON2, Mr = 212.25). Compound 3 was characterized by single-crystal X-ray diffraction analysis. The crystal belongs to orthorhombic,space group Pbca with a = 1.2889(11), b = 1.6170(14), c = 1.7729(15) nm, V= 3.695(6) nm^3, Z= 8, F(000) = 1536, Mr = 362.42, Dc = 1.303 g/cm^3, μ(MoKa) = 0.087 mm^-1, R = 0.0447 and wR= 0.0879. The crystal structure analysis indicates that the title compound has a two-dimensional network structure formed by hydrogen bonds and electrostatic interactions.     

Crystal Structure and Biological Activities of (R)-N''-[2-(4-Methoxy-6-chloro)-pyrimidinyl]-N-[3-methyl-2-(4-chlorophenyl)butyryl]-urea

The title compound (R)-N'-[2-(4-methoxy-6-chloro)-pyrimidyl]-N-[3-methyl-2-(4-chlorophenyl)butyryl]-urea has been synthesized, and its crystal structure and biological behaviors were studied. Crystallographic data: C17H18Cl2N4O3, Mr = 397.25, monoclinic, space group P21/c, a = 12.331 (2), b = 14.025(3), c = 23.085(5) (A), β = 99.607(4)°, Z = 8, V = 3936.2(13) (A)3, Dc = 1.341 g/cm3, F(000) = 1648, R = 0.0718, wR = 0.1585 and μ(MoKα) = 0.353 mm-1. The preliminary biological tests showed that the title compound has definite insecticidal and fungicidal activities.     

Synthesis, Crystal Structure and Fungicidal Activity of (E)-2-[(4-tert-Butyl-5- (4-methoxybenzyl)thiazol-2-ylimino)methyl]phenol

The title compound(E)-2-(4-tert-butyl-5-(4-methoxybenzyl)thiazol-2-ylimino)me-thylphenol was synthesized by the reaction of 5-(4-methoxybenzyl)-4-tert-butylthiazol-2-amine with salicylaldehyde=and its crystal structure was determined by single-crystal X-ray diffraction.The crystal belongs to the monoclinic system=space group P21/c with a=5.9362(8)=b=11.5070(15)=c=29.460(4)=β=97.326(3)°=V=1995.9(5)3=Z=4=F(000)=808=C22H24N2O2S=Mr=380.49=Dc=1.266 g/cm3=S=1.031=μ=0.181 mm--1=the final R=0.0474 and wR=0.1441 for 4327 observed reflections(I > 2σ(I)).Intramolecular O-H…N hydrogen bond is observed in the crystal.The preliminary bioassay showed that the title compound exhibits 95% inhibition rate against Rhizoctonia solani at the test concentration of 500 mg/L.     

Synthesis and Molecular Structure of (E)-1-(Morpholino)-2-(thiomethyl)-2-phenylvinylphosphonate

1 INTRODUCTION Phosphorus-containing vinyl compounds havebeen widely studied due to their versatile physiolo-gical activities and applications in transition metalchemistry, asymmetric catalysis and photorearrange-ment[1～4]. In our previous papers, we have reportedthe syntheses of 2,2,4,5-tetrasubstituted-1,3-dithio-les[5] and 2,5-bis(morpholino)-3,4-bis-(p-chloro-phe-nyl)thiophenes[6] by the reactions of α-thioaroyl-thiofor-mamide with trimethyl phosphite at room tempera-ture and in refl…     

三苯基锡-2-(1, 2-亚乙二硫)亚甲基-3-羰基-5-芳基-4-戊烯酸 酯的合成及晶体 结构

由2-(1,2-亚乙二硫)亚甲基-3-羰基-5-芳基-4-戊烯酸与三苯基氢氧化锡反应,合成了九个标题化合物3。用X射线衍射法测定了3b的晶体结构。该晶体属三斜晶系,空间群P1,a=0.9074(2)nm,b=1.6809(3)nm,c=2.1834(4)nm,α=77.57(3)ⅲ,β=88.04(3)ⅲ,γ=89.47(3)ⅲ,V=3.2503nm^3,Z=2;R=0.0592。由锡氧原子间距离可推测,该晶体中羧酸根作为双齿配体与锡原子形成了分子内五配位结构。     

Synthesis and Crystal Structure of [2-Hydroxy- 5-（4-hydroxy-3-phenyliminomethylbenzyl）-benzylidene]-phenyl-amine

The title compound [2-hydroxy-5-（4-hydroxy-3-phenyliminomethyl-benzyl）-benzylidene]-phenyl-amine （C27H22N2O2, Mr = 406.47） was synthesized by 5,5′-methylene-bissalicylal- dehyde with aminobenezene, and its crystal structure was determined by single-crystal X-ray diffraction. The crystal belongs to the monoclinic system, space group C2/c with a = 4.4026（6）, b = 1.501（13）, c = 0.95818（12） nm, β = 90.868（2）°, V= 4.2813（9） nm^3, Z= 8, Dc= 1.292 g/cm^3,μ = 0.010, F（000） = 1744, R = 0.0576 and wR = 0.1450 for 3766 observed reflections with I 〉 2σ（I）. X-ray analysis reveals that the molecule has a pair of intramolecular OH…N hydrogen bonds.     

Synthesis and Crystal Structure of (Z)-Ethyl-4-(4-methoxy)benzylidene-2-(3,5-dimethoxypheny-tetrahydrofuran-3,3-dicarboxylate

The title compound (Z)-ethyl-4-(4-methoxy)benzylidene-2-(3,5-dimethoxyphenyl)- tetrahydrofuran-3,3-dicarboxylate has been synthesized, and its crystal structure was characterized by X-ray single-crystal diffraction. The crystal belongs to triclinic, space group P1-, with a = 8.140(3), b = 11.966(4), c = 13.771(5) α = 67.366(4), β = 85.165(5), γ = 75.806(4)°, V = 1200.1(7) 3, Z = 2, C26H30O8, Mr = 470.50, Dc = 1.302 g/cm3, F(000) = 500, λ(MoKα) = 0.71073 , μ = 0.096 mm–1, R = 0.0659 and wR = 0.1841 for 3080 observed reflections (I > 2σ(I)). As a key intermediate of HIV-1 integrase inhibitor, the synthesis and structure confirmation of the title compound are important for further studies.